Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The role of metallothionein in breast cancer. (CROSBI ID 320220)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Bilić Knežević, Sara ; Tokić, Mirisa ; Gulić, Tamara ; Avirović, Manuela ; Grebić, Damir The role of metallothionein in breast cancer. // Libri oncologici : Croatian journal of oncology, 50 (2022), 2-3; 103-108

Podaci o odgovornosti

Bilić Knežević, Sara ; Tokić, Mirisa ; Gulić, Tamara ; Avirović, Manuela ; Grebić, Damir

engleski

The role of metallothionein in breast cancer.

Metallothioneins (MTs) are a family of small cysteine-rich proteins involved in many physiological and pathological processes. Genes that encode the four isoforms of metallothioneins (MT1-M4) are located on chromosome 16q13. Strucutures of these four isoforms allow metallothioneins their various biological functions. Many studies have shown that MT plays an important role in carcinogenesis, tumour growth, its progression from local to metastatic disease and may contribute to resistence to chemotherapy and radiotherapy. Due to the fact that breast cancer is one of the leading causes of death in women worldwide it is important to better understand the biology of breast cancer. So, findings of MT could evenutally help as a prognostic tool and could lead to a possible new specific anti-cancer treatment.

metallothionein ; breast cancer ; prognostic factor ; treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

50 (2-3)

2022.

103-108

objavljeno

0300-8142

2584-3826

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost